ABI
RMD icon

Adamant Biomedical Investments’s ResMed RMD Stock Holding History

Adamant Biomedical Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.12M Sell
20,000
-39,450
-66% -$2.06M 0.27% 80
2014
Q3 		$2.93M Buy
+59,450
New +$3.03M 0.73% 48

Other funds holding RMD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Adamant Biomedical Investments's RMD Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its ResMed (RMD) stake by 66% in Q4 2014, selling an estimated $2.06M and leaving 20,000 shares worth $1.12M. The position accounts for 0.27% of the portfolio, ranked #80.

Adamant Biomedical Investments first reported a position in RMD in Q3 2014 and has held it in 2 quarters since. The position peaked at $2.93M in Q3 2014. 308 funds tracked by Wall St. Rank hold RMD as of Q4 2014.

  • Adamant Biomedical Investments held 20,000 shares of ResMed worth $1.12M as of Q4 2014.
  • Adamant Biomedical Investments sold 39,450 ResMed shares in Q4 2014, an estimated $2.06M.
  • ResMed made up 0.27% of Adamant Biomedical Investments's portfolio in Q4 2014, its #80 holding.
  • Adamant Biomedical Investments first reported a position in ResMed in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's ResMed position peaked at $2.93M in Q3 2014.
  • 308 funds tracked by Wall St. Rank held ResMed as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.